UNIGE document Scientific Article
previous document  unige:43975  next document
add to browser collection
Title

Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial

Authors
Betticher, Daniel C
Hsu Schmitz, Shu-Fang
Hansen, Eva
Joss, Christine
von Briel, Christian
Schmid, Ralph A
Pless, Miklos
show hidden authors show all authors [1 - 20]
Published in Journal of Clinical Oncology. 2003, vol. 21, no. 9, p. 1752-9
Abstract A multicenter, phase II trial investigated the efficacy and toxicity of neoadjuvant docetaxel-cisplatin in locally advanced non-small-cell lung cancer (NSCLC) and examined prognostic factors for patients not benefiting from surgery.
Keywords AdultAgedAntineoplastic Combined Chemotherapy Protocols/therapeutic useCarcinoma, Non-Small-Cell Lung/drug therapy/pathology/surgeryCisplatin/administration & dosageFemaleHumansInfusions, IntravenousLung Neoplasms/drug therapy/pathology/surgeryLymphatic Metastasis/pathologyMaleMiddle AgedNeoadjuvant TherapyNeoplasm StagingPaclitaxel/administration & dosage/analogs & derivativesPrognosisSurvivalTaxoidsTreatment Outcome
Identifiers
PMID: 12721251
Full text
Article (Published version) (103 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Groupe Roth Arnaud (oncologie) (285)
Citation
(ISO format)
BETTICHER, Daniel C et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. In: Journal of Clinical Oncology, 2003, vol. 21, n° 9, p. 1752-9. https://archive-ouverte.unige.ch/unige:43975

156 hits

0 download

Update

Deposited on : 2014-12-19

Export document
Format :
Citation style :